Development and implementation of industrialized,fully automated high throughput screening systems

摘要

Automation has long been a resource for high-throughput screening at Bristol-Myers Squibb.However,with growing deck sizes and decreasing time lines,a new generation of more robust,supportable automated systems was necessary for accomplishing high-throughput screening goals.Implementation of this new generation of automated systems required numerous decisions concerning hardware,software and the value of in-house automation expertise.This project has resulted in fast,flexible,industrialized automation systems with a strong in-house support structure that we believe meets our current high-throughput screening requirements and will continue to meet them well into the future.